Navigation Links
NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
Date:6/5/2008

SAN MATEO, Calif., June 5 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that it is scheduled to present on Thursday, June 12, 2008 at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference. Anthony DiTonno, President and Chief Executive Officer, will be presenting at the conference and will be available for questions.

Event: Seventh Annual Needham & Company Biotechnology and

Medical Technology Conference

Date: Thursday, June 12, 2008

Time: 3:00 p.m. ET

Place: The New York Palace Hotel, New York, NY

An audio Web cast of the Company's presentations will be available by going to the investor relations section of NeurogesX' Web site at http://www.neurogesx.com. A replay of the presentation will be available for 15 days.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate NGX-4010, a dermal patch designed to manage pain associated with peripheral neuropathic pain condition
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007
2. NeurogesX to Present at RBC Capital Markets 2007 Healthcare Conference
3. NeurogesX to Present at Susquehanna Financial Groups 2nd Annual SIGnificant Options in Healthcare Conference
4. NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
5. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
6. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
7. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
8. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
10. AtriCure to Present at Roth Capital Partners 2007 New York Conference
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... WA (PRWEB) August 27, 2014 Sound ... call center solutions, and cloud-based business communication systems, has ... to Know about HIPAA-compliant Secure Text Messaging .” The ... healthcare professionals need to do to remain compliant with ... author of the article and C.O.O. at Sound Telecom, ...
(Date:8/27/2014)... August 27, 2014 Parker Waichman LLP, ... rights of victims injured by defective medical devices, reports ... for discovery procedures, specifically Collection and Preservation of Evidence, ... transvaginal mesh devices. (MDL No. 2187, In Re: C.R. ... United States District Court, Southern District or West Virginia; ...
(Date:8/27/2014)... half a glass of wine at a time may keep you ... asked 74 college students and staff to pour red and white ... of wine in them. The participants were told to pour an ... thumb" about how much to pour -- such as limiting it ... poured less wine than those without set guidelines. "About 70 ...
(Date:8/27/2014)... 2014 Power morcellator lawsuits ( http://www.gynecaremorcellatorlawsuit.com/ ... behalf of women who allegedly experienced the spread of ... reports. According to court documents, one of the most ... U.S. District Court, Northern District of New York, on ... of a power morcellator manufactured Karl Storz Endoscopy - ...
(Date:8/27/2014)... 27, 2014 When Jagger was 20 years ... his mother; one that he credits as one of the ... had news that she could set him up with a ... disabilities. Jagger took that job, and he has now spent ... past two decades, he also worked in school boards, employment ...
Breaking Medicine News(10 mins):Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4Health News:'Half a Glass' Rule May Curb Overdrinking 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4
... Oct. 27, 2011 Are children suffering needlessly after ... believe so. An operation can be one of ... a UCI study, many of them experience unnecessary postsurgical ... is well understood and treated in adults but has ...
... FINDINGS: Whitehead Institute scientists have determined that master transcription ... In this way, signaling pathways are targeted to genes ... tailor gene expression to control cell state, growth, differentiation, ... pathways operate properly, a cell receives instructions from its ...
... -- One of the things that makes inhalational anthrax so ... number of inhaled anthrax spores can turn into a lethal ... she has something worse than the flu and seeks treatment, ... be no help against the spreading bacteria and the potent ...
... and financially during adolescence and early adulthood takes its toll ... in middle aged men and women, irrespective of how tough ... E. Gustafsson from Ume University in Sweden and colleagues, experience ... into adulthood is linked to a rise in disease risk ...
... presence of a predator causes enough stress to kill a ... prey to eat it, say biologists at the University of ... eaten is an important topic in ecology, and we,ve learned ... prey interactions," says Professor Locke Rowe, chair of the Department ...
... The New England Regional Spinal Cord Injury Center at ... Spinal Cord Injury Model System (SCIMS) by the National ... are awarded in five-year cycles by the NIDRR through ... NIDRR supports innovative research in the delivery, demonstration ...
Cached Medicine News:Health News:How major signaling pathways are wired to our genome gives new insight into disease processes 2Health News:How major signaling pathways are wired to our genome gives new insight into disease processes 3Health News:Natural killer cells could be key to anthrax defense 2Health News:Hard times during adolescence point to health problems later in life 2Health News:Insects are scared to death of fish 2
(Date:8/27/2014)... , Aug. 27, 2014 About 8 ... legs due to buildup of fatty plaque in the ... the aging patient population and in incidences of diabetes ... offers its Lower Extremity Arterial RevascularizatioN (LEARN) ... Endovascular specialists and interested residents and fellows will ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Orthopedic ... http://www.reportlinker.com/p02316671/Global-Orthopedic-Soft-Tissue-Repair-Devices-Market-2014-2018.html About ... are the mass of cells that connect, support, ... orthopedic soft tissues such as tendons, ligaments, cartilage, ...
(Date:8/27/2014)... BURLINGTON, Mass. , Aug. 27, 2014 /PRNewswire/ ... six different specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, ... of clinical trials that a biosimilar has been ... which biosimilar product they choose to prescribe. ... Advisory Service report entitled Acceptance of ...
Breaking Medicine Technology:LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 3Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018 5Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2
... SOUTH EASTON, Mass., July 1 Pressure,BioSciences, Inc. ... scientists,from the New York University ("NYU") School of ... on advances they made in the,areas of breast ... The results were generated in studies using PBI,s ...
... Agennix Incorporated today announced,the publication of final results ... in patients who had failed previous treatment for,advanced ... the study,which were reported in the July 1 ... demonstrate that talactoferrin is active in RCC, has ...
Cached Medicine Technology:Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies 2Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 2Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 3Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 4Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma 5
... Medical Delta valve is designed to ... and maintain intraventricular pressure (IVP) within ... patient position. The normally closed Delta ... positive ventricular pressure. Working with the ...
... is an adjustable flow control valve in ... can be changed non-invasively by the caregiver. ... cerebrospinal fluid (CSF) and maintain intraventricular pressure ... of patient position. The normally closed Delta ...
...
... try Cadwell paired disc electrodes. They combine ... contacts are 10 mm (0.4 in) in ... steel with a locator pin on the ... and available in twisted pairs. Shielded paired ...
Medicine Products: